Vatiquinone

伐替苯醌

Report date: 2025/02/20 16:31:48
NMEFirst In Class

Base Information

Drug NameVatiquinone
Drug Alias Namevatiquinonum伐替喹酮vatiquinonaVincerenoneAlpha-tocotrienol quinone +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 15-lipoxygenase inhibitors
TargetsArachidonate 15-lipoxygenase
Therapy Area/IndicationsAutism Spectrum DisorderMitochondrial DiseasesRett Syndrome +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[13] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesEdison Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics IncSumitomo Dainippon Pharma Co Ltd
Inactive CompaniesEdison Pharmaceuticals IncYale UniversityUniversity Of South Florida +[4] 
Active IndicationsFriedreich Ataxia
Inactive IndicationsAutism Spectrum DisorderMitochondrial DiseasesRett Syndrome +[13] 

Other Information

ATC CodeN/A
Related LinksKEGG